Schwieler J H, Kahan T, Nussberger J, Johansson M C, Hjemdahl P
Department of Pharmacology, Karolinska Institute, Stockholm, Sweden.
Acta Physiol Scand. 1992 Aug;145(4):333-43. doi: 10.1111/j.1748-1716.1992.tb09373.x.
Interactions between angiotensin II and adrenoceptor-mediated effects on peripheral sympathetic neurotransmission were investigated in constant flow blood-perfused canine gracilis muscle in situ, without and with pretreatment by non-competitive alpha-adrenoceptor blockade. Angiotensin converting enzyme (ACE)-inhibition by benazeprilat increased nerve stimulation (2 Hz, 4 min)-evoked noradrenaline (NA) overflow (+ 21 +/- 5%) with alpha-adrenoceptors intact, but reduced NA overflow (- 18 +/- 6%) when alpha-adrenoceptors were blocked. Vasoconstrictor responses were slightly reduced by benazeprilat. Subsequent infusion of angiotensin II (Ang II, 20 and 500 ng kg-1 min-1 i.v., raising arterial concentrations from 0.6 +/- 0.2 pM to 1390 +/- 240 and 25,110 +/- 3980 pM, respectively) failed to increase NA overflow or to enhance stimulation-evoked vasoconstriction. Adrenaline (0.4 nmol kg-1 min-1 i.v.) did not change evoked NA overflow before or after benazeprilat, either with or without alpha-adrenoceptor blockade, despite high concentrations (approximately 10 nM) in arterial plasma. Following benazeprilat, propranolol reduced NA overflow (- 24 +/- 3%) only if the alpha-adrenoceptors were blocked. In conclusion, benazeprilat reduced evoked NA overflow in the presence of alpha-adrenoceptor blockade to a similar degree as previously shown in the presence of neuronal uptake inhibition in this model. However, contrasting to our previous findings, benazeprilat enhanced NA overflow and reduced the post-junctional response to nerve stimulation in the absence of alpha-adrenoceptor blockade. This could be related to bradykinin accumulation during ACE-inhibition, in addition to the reduction of Ang II generation. Our data are not compatible with facilitation of NA release by circulating Ang II even at pharmacological dose levels. Although activation of prejunctional beta-adrenoceptors may facilitate evoked NA overflow in this model, circulating adrenaline is ineffective under physiological conditions even after alpha-adrenoceptor blockade. Also, beta-adrenoceptor-mediated prejunctional effects do not seem to involve Ang II in canine skeletal muscle in vivo.
在犬原位恒流血液灌注的股薄肌中,研究了血管紧张素II与肾上腺素能受体介导的对外周交感神经传递的相互作用,实验分为未进行非竞争性α-肾上腺素能受体阻断预处理组和进行预处理组。在α-肾上腺素能受体完整的情况下,苯那普利拉抑制血管紧张素转换酶(ACE)可增加神经刺激(2 Hz,4分钟)诱发的去甲肾上腺素(NA)溢出(增加21±5%),但在α-肾上腺素能受体被阻断时,NA溢出减少(减少18±6%)。苯那普利拉使血管收缩反应略有降低。随后静脉输注血管紧张素II(Ang II,20和500 ng kg-1 min-1,使动脉浓度分别从0.6±0.2 pM升高至1390±240和25110±3980 pM)未能增加NA溢出或增强刺激诱发的血管收缩。肾上腺素(0.4 nmol kg-1 min-1静脉注射)在苯那普利拉给药前后,无论α-肾上腺素能受体是否被阻断,均未改变诱发的NA溢出,尽管动脉血浆中浓度较高(约10 nM)。苯那普利拉给药后,仅在α-肾上腺素能受体被阻断时,普萘洛尔才会降低NA溢出(减少24±3%)。总之,在α-肾上腺素能受体被阻断的情况下,苯那普利拉降低诱发的NA溢出的程度与该模型中先前在存在神经元摄取抑制时所显示的程度相似。然而,与我们之前的发现相反,在不存在α-肾上腺素能受体阻断的情况下,苯那普利拉增强了NA溢出并降低了对神经刺激的节后反应。这可能与ACE抑制过程中缓激肽的积累有关,此外还与Ang II生成的减少有关。即使在药理剂量水平,我们的数据也不支持循环中的Ang II促进NA释放 的观点。虽然在该模型中,节前β-肾上腺素能受体的激活可能促进诱发的NA溢出,但即使在α-肾上腺素能受体被阻断后,循环中的肾上腺素在生理条件下也无效。此外,在犬体内骨骼肌中,β-肾上腺素能受体介导的节前效应似乎不涉及Ang II。